Alector to Participate in Upcoming Healthcare Conferences
ALECSOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in the following upcoming investor conferences:
HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $10
ALECAlector Q1 EPS $(0.41) Beats $(0.48) Estimate, Sales $3.67M Miss $4.38M Estimate
ALEC12 Health Care Stocks Moving In Friday's Pre-Market Session
ALEC12 Health Care Stocks Moving In Thursday's After-Market Session
ALECAlector Completes Enrollment In PROGRESS-AD Phase 2 Clinical Trial If AL101/GSK4527226 For Individuals With Early Alzheimer's Disease
ALECMorgan Stanley Assumes Alector at Underweight, Lowers Price Target of $1.5
ALECHC Wainwright & Co. Reiterates Buy on Alector, Maintains $7 Price Target
ALECAlector Sees FY2025 collaboration revenue to be between $5 million and $15 million
ALECAlector Q4 2024 GAAP EPS $(0.02) Up From $(0.49) YoY, Sales $54.240M Beat $16.621M Estimate
ALECAlector Highlights Strategic Focus For 2025, Phase 3 INFRONT-3 Data On Latozinemab For FTD-GRN By Q4 2025; 75% Enrollment For AL101 Trial In Early Alzheimer's Achieved; $457.2M Cash Expected To Fund Operations Through 2026
ALECAlector Q3 EPS $(0.43) Beats $(0.53) Estimate, Sales $15.34M Miss $15.70M Estimate
ALECAlector Initiates Phase 1 Clinical Trial Of AL044 For The Treatment Of Alzheimer's Disease
ALECDow Climbs More Than 400 Points, S&P 500 Rises 1.5%
ALECU.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday.
Morgan Stanley Downgrades Alector: Here's What You Need To Know
ALECMorgan Stanley downgraded its rating of Alector (NASDAQ:ALEC) to Equal-Weight with a price target of $13.00, changing its price target from $27.00 to $13.00.
Shares of Alector are trading down 12.47% over the last 24 hours, at $9.62 per share.
Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply
ALECU.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday.
Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday
ALECU.S. stocks traded higher, with the Dow Jones gaining around 300 points on Friday. Here are some big stocks recording gains in today’s session.
Morgan Stanley Downgrades Alector to Equal-Weight, Lowers Price Target to $13
ALEC